Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

Paul van der Leest, Birgitta Hiddinga, Anneke Miedema, Maria L Aguirre Azpurua, Naomi Rifaela, Arja Ter Elst, Wim Timens, Harry J M Groen, Léon C van Kempen, T Jeroen N Hiltermann, Ed Schuuring*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)
218 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases